Refractory, advanced sezany syndrome
Also known as: Refractory Sezary Syndrome / Refractory, advanced Sezary Syndrome / Sezary syndrome refractory / Sezary's syndrome refractory / Sezary's disease refractory / Cutaneous T-cell lymphoma refractory
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00853 | Temozolomide | An alkylating agent used to treat glioblastoma multiforme and refractory anaplastic astrocytoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00853 | Temozolomide | DNA | target |
| DB00853 | Temozolomide | Serum albumin | carrier |
| DB00853 | Temozolomide | Alpha-1-acid glycoprotein 1 | carrier |
| DB00853 | Temozolomide | P-glycoprotein 1 | transporter |
| DB00853 | Temozolomide | ATP-binding cassette sub-family G member 2 | transporter |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16225 | Magrolimab | 1 / 2 | Active Not Recruiting | 1 |
| DB12498 | Mogamulizumab | 1 / 2 | Active Not Recruiting | 1 |